Edwards Lifesciences Corporation Net Realized and Unrealized Gain (Loss) on Trading Securities
Edwards Lifesciences Corporation (EW) reported Net Realized and Unrealized Gain (Loss) on Trading Securities of $1.00 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-28.
Discontinued › Income Statement › Other Income
us-gaap:NetRealizedOrUnrealizedGainLossOnTradingSecurities · last filed 2014-02-28
- Edwards Lifesciences Corporation net realized and unrealized gain (loss) on trading securities for the quarter ending 2010-12-31 was $1.20M, a 71.43% increase year-over-year.
- Edwards Lifesciences Corporation net realized and unrealized gain (loss) on trading securities for the quarter ending 2010-09-30 was $1.70M, a 6.25% increase year-over-year.
- Edwards Lifesciences Corporation net realized and unrealized gain (loss) on trading securities for the quarter ending 2009-12-31 was $700.00K.
- Edwards Lifesciences Corporation net realized and unrealized gain (loss) on trading securities for the quarter ending 2009-09-30 was $1.60M.
- Edwards Lifesciences Corporation net realized and unrealized gain (loss) on trading securities for fiscal 2013 was $1.00M, a 42.86% increase from fiscal 2012.
- Edwards Lifesciences Corporation net realized and unrealized gain (loss) on trading securities for fiscal 2012 was $700.00K.
- Edwards Lifesciences Corporation net realized and unrealized gain (loss) on trading securities for fiscal 2011 was -$1.00M, a 137.04% decline from fiscal 2010.
- Edwards Lifesciences Corporation net realized and unrealized gain (loss) on trading securities for fiscal 2010 was $2.70M, a 18.18% decline from fiscal 2009.
| Period end | Net Realized and Unrealized Gain (Loss) on Trading Securities 3 month | Net Realized and Unrealized Gain (Loss) on Trading Securities 6 month | Net Realized and Unrealized Gain (Loss) on Trading Securities 9 month | Net Realized and Unrealized Gain (Loss) on Trading Securities 12 month |
|---|---|---|---|---|
| 2013-12-31 | $1.00M 10-K · filed 2014-02-28 | |||
| 2012-12-31 | $700.00K 10-K · filed 2014-02-28 | |||
| 2011-12-31 | -$1.00M 10-K · filed 2014-02-28 | |||
| 2010-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $2.90M derived: sum of 2 quarters · filed 2013-02-28 | $2.70M 10-K · filed 2013-02-28 | |
| 2010-09-30 | $1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $1.50M 10-Q · filed 2010-11-08 | ||
| 2010-06-30 | -$200.00K 10-Q · filed 2010-08-06 | |||
| 2009-12-31 | $700.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $2.30M derived: sum of 2 quarters · filed 2012-02-27 | $3.30M 10-K · filed 2012-02-27 | |
| 2009-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $2.60M 10-Q · filed 2010-11-08 | ||
| 2009-06-30 | $1.00M 10-Q · filed 2010-08-06 | |||
| 2008-12-31 | -$4.90M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |